State Street Corp Novo Cure LTD Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Novo Cure LTD stock. As of the latest transaction made, State Street Corp holds 2,729,988 shares of NVCR stock, worth $46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,729,988

Previous 3,005,689 9.17%

Holding current value

$46 Million

Previous $51.5 Million 17.13%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $4.3 Million - $6.43 Million	-275,701 Reduced 9.17%	2,729,988 $42.7 Million
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $4.23 Million - $8.59 Million	-357,176 Reduced 10.62%	3,005,689 $51.5 Million
Q1 2024 May 15, 2024	SELL	$12.42 - $17.29 $6.22 Million - $8.66 Million	-500,684 Reduced 12.96%	3,362,865 $52.6 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $19.7 Million - $27.9 Million	1,770,927 Added 84.63%	3,863,549 $57.7 Million
Q3 2023 Nov 14, 2023	SELL	$16.15 - $42.35 $6.04 Million - $15.8 Million	-374,012 Reduced 15.16%	2,092,622 $33.8 Million
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $12.2 Million - $25.1 Million	-303,974 Reduced 10.97%	2,466,634 $102 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $30.1 Million - $63.3 Million	532,958 Added 23.82%	2,770,608 $167 Million
Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $24.8 Million - $33.1 Million	-387,188 Reduced 14.75%	2,237,650 $164 Million
Q3 2022 Nov 15, 2022	BUY	$67.99 - $89.57 $22.9 Million - $30.1 Million	336,243 Added 14.69%	2,624,838 $199 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $11.9 Million - $18.9 Million	-209,974 Reduced 8.4%	2,288,595 $159 Million
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $527,816 - $741,663	8,775 Added 0.35%	2,498,569 $207 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $21.5 Million - $34.9 Million	286,247 Added 12.99%	2,489,794 $187 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $5.23 Million - $8.76 Million	-45,038 Reduced 2.0%	2,203,547 $256 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $26.2 Million - $45.3 Million	200,689 Added 9.8%	2,248,585 $499 Million
Q1 2021 Jul 09, 2021	BUY	$124.11 - $190.17 $15.9 Million - $24.4 Million	128,049 Added 6.67%	2,047,896 $271 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $1.84 Million - $2.82 Million	-14,834 Reduced 0.77%	1,919,847 $254 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $87.8 Million - $136 Million	782,901 Added 67.97%	1,934,681 $335 Million
Q3 2020 Nov 10, 2020	BUY	$58.05 - $111.31 $3.75 Million - $7.19 Million	64,557 Added 5.94%	1,151,780 $128 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $37.5 Million - $48.8 Million	-655,368 Reduced 37.61%	1,087,223 $64.5 Million
Q1 2020 May 11, 2020	BUY	$57.05 - $95.75 $99.4 Million - $167 Million	1,742,591 New	1,742,591 $117 Million

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.77B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Novo Cure LTD Transaction History